|
|
Blood, 1 January 2006, Vol. 107, No. 1, pp. 265-276.
Prepublished online as a Blood First Edition Paper on September 8, 2005; DOI 10.1182/blood-2005-06-2508.
 Previous Article | Table of Contents | Next Article 
NEOPLASIA
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001
Lindsay M. Morton,
Sophia S. Wang,
Susan S. Devesa,
Patricia Hartge,
Dennis D. Weisenburger, and
Martha S. Linet
From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Rockville, MD; and Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha.
Because the causes of most lymphoid neoplasms remain unknown, comparison of incidence patterns by disease subtype may provide critical clues for future etiologic investigations. We therefore conducted a comprehensive assessment of 114 548 lymphoid neoplasms diagnosed during 1992-2001 in 12 Surveillance, Epidemiology, and End Results (SEER) registries according to the internationally recognized World Health Organization (WHO) lymphoma classification introduced in 2001. Cases coded in International Classification of Diseases for Oncology, Second Edition (ICD-O-2), were converted to ICD-O-3 for WHO subtype assignment. Age-specific and age-adjusted rates were compared by sex and race (white, black, Asian). Age-adjusted trends in incidence were estimated by sex and race using weighted least squares log-linear regression. Diverse incidence patterns and trends were observed by lymphoid neoplasm subtype and population. In the elderly (75 years or older), rates of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma increased 1.4% and 1.8% per year, respectively, whereas rates of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) declined 2.1% per year. Although whites bear the highest incidence burden for most lymphoid neoplasm subtypes, most notably for hairy cell leukemia and follicular lymphoma, black predominance was observed for plasma cell and T-cell neoplasms. Asians have considerably lower rates than whites and blacks for CLL/SLL and Hodgkin lymphoma. We conclude that the striking differences in incidence patterns by histologic subtype strongly suggest that there is etiologic heterogeneity among lymphoid neoplasms and support the pursuit of epidemiologic analysis by subtype.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. Koshiol, G. Gridley, E. A. Engels, M. L. McMaster, and O. Landgren
Chronic Immune Stimulation and Subsequent Waldenstrom Macroglobulinemia
Arch Intern Med,
September 22, 2008;
168(17):
1903 - 1909.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Klapper, M. Szczepanowski, B. Burkhardt, H. Berger, M. Rosolowski, S. Bentink, C. Schwaenen, S. Wessendorf, R. Spang, P. Moller, et al.
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials
Blood,
August 15, 2008;
112(4):
1374 - 1381.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Zhang, S. D. Sanjose, P. M. Bracci, L. M. Morton, R. Wang, P. Brennan, P. Hartge, P. Boffetta, N. Becker, M. Maynadie, et al.
Personal Use of Hair Dye and the Risk of Certain Subtypes of Non-Hodgkin Lymphoma
Am. J. Epidemiol.,
June 1, 2008;
167(11):
1321 - 1331.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. B. Yu, R. C. Blitzblau, R. H. Decker, D. M. Housman, and L. D. Wilson
Analysis of Primary CD30+ Cutaneous Lymphoproliferative Disease and Survival From the Surveillance, Epidemiology, and End Results Database
J. Clin. Oncol.,
March 20, 2008;
26(9):
1483 - 1488.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Maskarinec, E. Erber, J. Gill, W. Cozen, and L. N. Kolonel
Overweight and Obesity at Different Times in Life as Risk Factors for Non-Hodgkin's Lymphoma: The Multiethnic Cohort
Cancer Epidemiol. Biomarkers Prev.,
January 1, 2008;
17(1):
196 - 203.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Cerhan, S. M. Ansell, Z. S. Fredericksen, N. E. Kay, M. Liebow, T. G. Call, A. Dogan, J. M. Cunningham, A. H. Wang, W. Liu-Mares, et al.
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma
Blood,
December 15, 2007;
110(13):
4455 - 4463.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Czene, H.-O. Adami, and E. T. Chang
Sex- and Kindred-Specific Familial Risk of Non Hodgkin's Lymphoma
Cancer Epidemiol. Biomarkers Prev.,
November 1, 2007;
16(11):
2496 - 2499.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Lim, L. M. Morton, A. F. Subar, D. Baris, R. Stolzenberg-Solomon, M. Leitzmann, V. Kipnis, T. Mouw, L. Carroll, A. Schatzkin, et al.
Alcohol, Smoking, and Body Size in Relation to Incident Hodgkin's and Non-Hodgkin's Lymphoma Risk
Am. J. Epidemiol.,
September 15, 2007;
166(6):
697 - 708.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Joshi, G. V. Hegde, J. D. Dickinson, A. K. Mittal, J. C. Lynch, J. D. Eudy, J. O. Armitage, P. J. Bierman, R. G. Bociek, M. P. Devetten, et al.
ATM, CTLA4, MNDA, and HEM1 in High versus Low CD38 Expressing B-Cell Chronic Lymphocytic Leukemia
Clin. Cancer Res.,
September 15, 2007;
13(18):
5295 - 5304.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Morton, J. J. Turner, J. R. Cerhan, M. S. Linet, P. A. Treseler, C. A. Clarke, A. Jack, W. Cozen, M. Maynadie, J. J. Spinelli, et al.
Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)
Blood,
July 15, 2007;
110(2):
695 - 708.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Cerhan, S. Wang, M. J. Maurer, S. M. Ansell, S. M. Geyer, W. Cozen, L. M. Morton, S. Davis, R. K. Severson, N. Rothman, et al.
Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival
Blood,
June 15, 2007;
109(12):
5439 - 5446.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Robertson, B. S. Kahl, J. M. Vose, S. de Vos, M. Laughlin, P. J. Flynn, K. Rowland, J. C. Cruz, S. L. Goldberg, L. Musib, et al.
Phase II Study of Enzastaurin, a Protein Kinase C Beta Inhibitor, in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
J. Clin. Oncol.,
May 1, 2007;
25(13):
1741 - 1746.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. McCaw, A. S. Chan, A. L. Stegner, B. Mooney, J. N. Bryan, S. E. Turnquist, C. J. Henry, H. Alexander, and S. Alexander
Proteomics of Canine Lymphoma Identifies Potential Cancer-Specific Protein Markers
Clin. Cancer Res.,
April 15, 2007;
13(8):
2496 - 2503.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Wang, S. L. Slager, P. Brennan, E. A. Holly, S. De Sanjose, L. Bernstein, P. Boffetta, J. R. Cerhan, M. Maynadie, J. J. Spinelli, et al.
Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)
Blood,
April 15, 2007;
109(8):
3479 - 3488.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Lim, S. S. Wang, P. Hartge, W. Cozen, L. E. Kelemen, S. Chanock, S. Davis, A. Blair, M. Schenk, N. Rothman, et al.
Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER Case-Control Study
Blood,
April 1, 2007;
109(7):
3050 - 3059.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. C.-H. Chiu, B. J. Dave, A. Blair, S. M. Gapstur, J. S. Chmiel, A. J. Fought, S. H. Zahm, and D. D. Weisenburger
Cigarette Smoking, Familial Hematopoietic Cancer, Hair Dye Use, and Risk of t(14;18)-defined Subtypes of Non-Hodgkin's Lymphoma
Am. J. Epidemiol.,
March 15, 2007;
165(6):
652 - 659.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. E. Grulich, C. M. Vajdic, and W. Cozen
Altered Immunity as a Risk Factor for Non-Hodgkin Lymphoma
Cancer Epidemiol. Biomarkers Prev.,
March 1, 2007;
16(3):
405 - 408.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. C-H. Chiu, S. M. Gapstur, P. Greenland, R. Wang, and A. Dyer
Body Mass Index, Abnormal Glucose Metabolism, and Mortality from Hematopoietic Cancer
Cancer Epidemiol. Biomarkers Prev.,
December 1, 2006;
15(12):
2348 - 2354.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Paltiel, D. E. Laniado, R. Yanetz, L. Deutsch, R. Calderon-Margalit, S. Harlap, and Y. Friedlander
The Risk of Cancer following Hospitalization for Infection in Infancy: A Population-Based Cohort Study.
Cancer Epidemiol. Biomarkers Prev.,
October 1, 2006;
15(10):
1964 - 1968.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. D. Shanafelt, J. C. Byrd, T. G. Call, C. S. Zent, and N. E. Kay
Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemia.
Ann Intern Med,
September 19, 2006;
145(6):
435 - 447.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Sandin, H. Hjalgrim, B. Glimelius, K. Rostgaard, E. Pukkala, and J. Askling
Incidence of Non-Hodgkin's Lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an Epidemic That Was.
Cancer Epidemiol. Biomarkers Prev.,
July 1, 2006;
15(7):
1295 - 1300.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Dave, K. Fu, G. W. Wright, L. T. Lam, P. Kluin, E.-J. Boerma, T. C. Greiner, D. D. Weisenburger, A. Rosenwald, G. Ott, et al.
Molecular diagnosis of Burkitt's lymphoma.
N. Engl. J. Med.,
June 8, 2006;
354(23):
2431 - 2442.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Lim, S. Weinstein, D. Albanes, P. Pietinen, L. Teerenhovi, P. R. Taylor, J. Virtamo, and R. Stolzenberg-Solomon
Dietary factors of one-carbon metabolism in relation to non-hodgkin lymphoma and multiple myeloma in a cohort of male smokers.
Cancer Epidemiol. Biomarkers Prev.,
June 1, 2006;
15(6):
1109 - 1114.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
